Application of clerodane diterpene in preparation of medicine for preventing and treating non-alcoholic fatty liver disease
The invention belongs to the field of biological medicine, and discloses application of a clerodane diterpene compound montanin B shown in a formula I in preparation of a medicine for preventing or treating non-alcoholic fatty liver disease. The compound montanin B disclosed by the invention can remarkably promote reduction of fat accumulation in liver cells induced by high fat, is free of cytotoxicity, and has good application and development prospects in the field of medicines..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 22. Dez. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
MA SHUANGGANG [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-12-22, Last update posted on www.tib.eu: 2024-03-13, Last updated: 2024-03-22 |
|---|
| Patentnummer: |
CN117257793 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA000472123 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA000472123 | ||
| 003 | DE-627 | ||
| 005 | 20240322142142.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240315s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA000472123 | ||
| 035 | |a (EPA)CN117257793 | ||
| 035 | |a (EPA)89206786 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a MA SHUANGGANG |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Application of clerodane diterpene in preparation of medicine for preventing and treating non-alcoholic fatty liver disease |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-12-22, Last update posted on www.tib.eu: 2024-03-13, Last updated: 2024-03-22 | ||
| 520 | |a The invention belongs to the field of biological medicine, and discloses application of a clerodane diterpene compound montanin B shown in a formula I in preparation of a medicine for preventing or treating non-alcoholic fatty liver disease. The compound montanin B disclosed by the invention can remarkably promote reduction of fat accumulation in liver cells induced by high fat, is free of cytotoxicity, and has good application and development prospects in the field of medicines. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a YU SHISHAN |4 aut | |
| 700 | 0 | |a YANG XIUYING |4 aut | |
| 700 | 0 | |a DU GUANHUA |4 aut | |
| 700 | 0 | |a QIANG GUIFEN |4 aut | |
| 700 | 0 | |a LIU YUNBAO |4 aut | |
| 700 | 0 | |a LI YONG |4 aut | |
| 700 | 0 | |a LI NA |4 aut | |
| 700 | 0 | |a HUO KANGYING |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 22. Dez. |
| 773 | 1 | 8 | |g year:2023 |g day:22 |g month:12 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/89206786/publication/CN117257793A1?q=CN117257793 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 22 |c 12 | ||